Data / Form D filings / CEL SCI CORP
CEL SCI CORP: Form D filings
CEL SCI CORP, a biotechnology company in Vienna, VA, filed 3 Form D notices with the SEC between 2017 and 2018. The latest, on July 11, 2018, reports $78,000 sold of a $78,000 offering to 4 investors.
Find out what CEL SCI CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8229 BOONE BLVD ., SUITE 802, Vienna, VA, 22182
- Phone
- (703) 506-9460
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Colorado
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 725363
The full lists. Form D filings in Virginia: 771 rows, $38.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 11, 2018 | New notice | $78,000 | $78,000 | $0 | 4 | Jul 2, 2018 | sec.gov |
| Jul 17, 2017 | New notice | $1,510,000 | $0 | $1,510,000 | 6 | Jun 22, 2017 | sec.gov |
| Feb 28, 2017 | New notice | $1,000,000 | $1,000,000 | $0 | 2 | Feb 16, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter R. Young | Director | |
| Robert R. Watson | Director | |
| Geert Kersten | Executive Officer, Director | |
| Eyal B. Talor | Executive Officer | |
| John H. Cipriano | Executive Officer | |
| Bruno R. Bailavoine | Director | |
| Patricia B. Prichep | Executive Officer | |
| Daniel H. Zimmerman | Executive Officer |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Jul 9, 2018 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CEL SCI CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.